Similarly, epigenetically repressed expression of the proapoptotic BAK (Bcl-2 homologous antagonist/killer) gene in IPF fibroblasts was shown to be reversed in response to HDAC-inhibitor treatment [164]. The gene discussed is HDAC9; the disease is idiopathic pulmonary fibrosis.